{"transactions":[{"id":2074446,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":121229,"kind":"person","name":"Farb Daniel Stuart","position":1,"cik":"0001776353","reported_name":"Farb Daniel Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-30T21:05:56.000Z","date":"2022-12-28","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the \"2022 Plan\"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the \"2022 Plan\"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.97,"exercise_date":"2022-12-28","expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001683168-22-008707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822008707/ownership.xml","form_type":"4"}}]}